Introduction Severe COVID‐19 management is still challenging. Having a laboratory factor
to predict the severity of a patient's condition can be very useful in how to approach each …

Background Data for predicting severity of patients with COVID-19 infection are sparse and
still under investigation. We retrospectively studied whether the admission serum C-reactive …

Background: Despite being very infectious and fatal, the coronavirus disease 2019 (COVID-
19) lacks a reliable and practical biomarker to assess how serious it will be. Aim: The current …

Background Clinical findings indicated that a fraction of coronavirus disease 2019 (COVID-
19) patients diagnosed as mild early may progress to severe cases. However, it is difficult to …

Recent studies have reported that CRP levels are elevated in patients with COVID-19 and
may correlate with severity of disease and disease progression. We conducted a …

Background A systemic inflammatory response is observed in coronavirus disease 2019
(COVID-19). Elevated serum levels of C-reactive protein (CRP), a marker of systemic …

While some biomolecules have been explored to identify potential biomarkers for the
prognosis of COVID‐19 patients, there is no reliable prognostic indicator of the disease …

C-reactive protein (CRP) is a cytokine-mediated acute phase reactant with a recognized role
in inflammatory conditions and infectious disease. In coronavirus disease 2019 (COVID-19) …

Abstract Coronavirus disease 2019 (COVID-19) is an infectious disease that can develop
multiple complications and even be life-threatening. The aim of this study is to summarize …

Background The novel coronavirus disease 2019 (COVID-19) first broke out in Wuhan,
China, spread over 227 countries and caused approximately 0.3 million death worldwide …